Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer.
Saved in:
| Title: | Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer. |
|---|---|
| Authors: | Labiano I; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Guerrero-Setas D; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Huerta AE; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Mata E; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Alkorta-Aranburu G; CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Ordoñez GR; Department of Personalized Medicine & Laboratories, NASERTIC, Government of Navarra, Pamplona, Spain., Berraondo P; Programme of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Lecumberri A; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Ochoa P; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Caseda I; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Termini R; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Agirre-Mikelarena B; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Amat I; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Castro N; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Arasanz H; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Alsina M; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain. maria.alsina.maqueda@navarra.es.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. maria.alsina.maqueda@navarra.es., Vera R; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. |
| Source: | Scientific reports [Sci Rep] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42310061 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Labiano+I%22">Labiano I</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Guerrero-Setas+D%22">Guerrero-Setas D</searchLink>; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Huerta+AE%22">Huerta AE</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Mata+E%22">Mata E</searchLink>; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Alkorta-Aranburu+G%22">Alkorta-Aranburu G</searchLink>; CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ordoñez+GR%22">Ordoñez GR</searchLink>; Department of Personalized Medicine & Laboratories, NASERTIC, Government of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Berraondo+P%22">Berraondo P</searchLink>; Programme of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lecumberri+A%22">Lecumberri A</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ochoa+P%22">Ochoa P</searchLink>; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Caseda+I%22">Caseda I</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Termini+R%22">Termini R</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Agirre-Mikelarena+B%22">Agirre-Mikelarena B</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Amat+I%22">Amat I</searchLink>; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Castro+N%22">Castro N</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.<br /><searchLink fieldCode="AU" term="%22Arasanz+H%22">Arasanz H</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Alsina+M%22">Alsina M</searchLink>; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain. maria.alsina.maqueda@navarra.es.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. maria.alsina.maqueda@navarra.es.<br /><searchLink fieldCode="AU" term="%22Vera+R%22">Vera R</searchLink>; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2026 Jun 18. <i>Date of Electronic Publication: </i>2026 Jun 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42310061 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-026-58101-0 Languages: – Code: eng Text: English Titles: – TitleFull: Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Labiano I – PersonEntity: Name: NameFull: Guerrero-Setas D – PersonEntity: Name: NameFull: Huerta AE – PersonEntity: Name: NameFull: Mata E – PersonEntity: Name: NameFull: Alkorta-Aranburu G – PersonEntity: Name: NameFull: Ordoñez GR – PersonEntity: Name: NameFull: Berraondo P – PersonEntity: Name: NameFull: Lecumberri A – PersonEntity: Name: NameFull: Ochoa P – PersonEntity: Name: NameFull: Caseda I – PersonEntity: Name: NameFull: Termini R – PersonEntity: Name: NameFull: Agirre-Mikelarena B – PersonEntity: Name: NameFull: Amat I – PersonEntity: Name: NameFull: Castro N – PersonEntity: Name: NameFull: Arasanz H – PersonEntity: Name: NameFull: Alsina M – PersonEntity: Name: NameFull: Vera R IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2026 Jun 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2045-2322 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |